| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/14/2007 | EP1762557A2 Aspirin-triggered lipid mediators |
| 03/14/2007 | EP1761261A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 03/14/2007 | EP1761259A2 Topical formulations for treating allergic diseases |
| 03/14/2007 | EP1761254A1 Improvement of image quality in the eye |
| 03/14/2007 | EP1761253A2 Hyaluronic acid in the enhancement of lens regeneration |
| 03/14/2007 | EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 03/14/2007 | EP1502595B1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof |
| 03/14/2007 | EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same |
| 03/14/2007 | EP1305434B1 A human disintegrin protein |
| 03/14/2007 | EP1242083B1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 03/14/2007 | EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1927392A Composite collagen eye drops |
| 03/14/2007 | CN1927391A Collagen eye drops |
| 03/14/2007 | CN1927347A Chinese medicinal herb for preventing and treating myopia prevention |
| 03/14/2007 | CN1927335A Traditional medicine preparation for treating diabetic retinopathy |
| 03/14/2007 | CN1927295A Eye protecting nutritious liquid |
| 03/14/2007 | CN1927195A Film agent comprising sodium gualenate using for eyes |
| 03/14/2007 | CN1927168A Implantation slow release medicine in eyes |
| 03/14/2007 | CN1304567C Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 03/14/2007 | CN1304052C Medicinal compositions for application to mucosa |
| 03/14/2007 | CN1304047C Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 03/14/2007 | CN1303999C Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same |
| 03/13/2007 | US7189878 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy |
| 03/13/2007 | US7189742 For therapy of disorder associated with elevated levels of 5-HT (5-hydroxytryptamine; serotonin) resultant from newly synthesised 5-HT, anxiety, depression, migraine and sleep apnoea |
| 03/13/2007 | US7189741 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/13/2007 | US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders |
| 03/13/2007 | US7189719 Sodium channel blockers |
| 03/13/2007 | US7189404 Strain selection of pneumococcal surface proteins |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2273010C Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts |
| 03/13/2007 | CA2271026C 3-amino-propoxyphenyl derivatives |
| 03/13/2007 | CA2219280C Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 03/13/2007 | CA2192209C Treatment of optic neuritis |
| 03/08/2007 | WO2007027761A2 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 03/08/2007 | WO2007027468A1 Ep2 receptor agonists for treating glaucoma |
| 03/08/2007 | WO2007026966A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | WO2007026962A1 Phenylene derivative |
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | WO2007026664A1 Sulfonamide compound |
| 03/08/2007 | WO2007026630A1 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 03/08/2007 | WO2007026215A1 Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation |
| 03/08/2007 | WO2007025347A1 Prophylactic and therapeutic agents and uses therefor |
| 03/08/2007 | WO2006127592A3 Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts |
| 03/08/2007 | WO2006099445A3 Nanocells for diagnosis and treatment of diseases and disorders |
| 03/08/2007 | WO2006075020A3 Ampa antagonist for the treatment of dizziness, including vertigo and meniere's disorder |
| 03/08/2007 | WO2006042329A3 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 03/08/2007 | US20070054943 Therapeutic agent for keratoconjunctival disorder |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054861 Therapeutic uses of SMR1 peptides |
| 03/08/2007 | US20070053964 Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| 03/08/2007 | US20070053902 Anti-alphabeta3 humanized monoclonal antibodies |
| 03/08/2007 | DE10161149B4 Verwendung von Heparin-haltigem Ophthalmikum Use of heparin-containing ophthalmic |
| 03/08/2007 | CA2621086A1 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 03/08/2007 | CA2620809A1 Prophylactic and therapeutic agents and uses therefor |
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2619445A1 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 03/08/2007 | CA2602442A1 Ep2 receptor agonists for treating glaucoma |
| 03/07/2007 | EP1759702A1 Method of preparing a latanoprost ophthalmic solution and solution thus produced |
| 03/07/2007 | EP1759597A2 Antiallergic composition |
| 03/07/2007 | EP1758567A1 Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye |
| 03/07/2007 | EP1758552A1 Intraocular implants of alpha-2 adrenergic receptor agonists and methods for improving vision |
| 03/07/2007 | EP1457212B1 Eye drops |
| 03/07/2007 | EP1368304B1 Prodrugs of excitatory amino acids |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP0831797B1 Pharmaceutically active carotenoids |
| 03/07/2007 | CN1923209A Phthiobuzonum eye drops containing sodium hyaluronate and its preparing process |
| 03/07/2007 | CN1923203A Boletic acid ketotifen eye drops containing sodium hyaluronate and its preparing process |
| 03/07/2007 | CN1303072C 7-oxo pyridopyrimidines |
| 03/07/2007 | CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/07/2007 | CN1302812C Transmission system of medicine containing trehalose and hyaluronic acid for eye part and its preparation method |
| 03/07/2007 | CN1302810C Optic nerve protecting agents containing alpha1 receptor blocker as the active ingredient |
| 03/07/2007 | CN1302778C Dispersible tablet of acetazolamide and its preparation method |
| 03/06/2007 | US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 03/06/2007 | US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/06/2007 | US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | US7186706 For improving health in a woman having elevated sex hormone binding globulin levels, or who is receiving oral estrogen supplementation |
| 03/06/2007 | US7186703 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/06/2007 | CA2355313C Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 03/06/2007 | CA2186243C Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity |
| 03/01/2007 | WO2007024611A2 Sulfonamides of 7 -aminoheptanoic acid derivatives for treating glaucoma |
| 03/01/2007 | WO2007024008A1 Preventive or therapeutic agent for side effect based on cytotoxicity of anticancer therapy containing apoptosis inhibition activity-enhancing protein fnk or nucleic acid encoding the same |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023877A1 Remedy for corneal diseases |
| 03/01/2007 | WO2007023774A1 Agent for amelioration of impaired ophthalmic arterial blood flow |